Marker Therapeutics, Inc. (MRKR)

1.435 +0.04 (+3.24%) USD  |  NASDAQ  |  Dec 26, 16:00
1.435 0.00 (0.00%) After-Hours: 20:00
More

Marker Therapeutics Changes in Working Capital (Quarterly)

Changes in Working Capital (Quarterly) Chart

View Changes in Working Capital (Quarterly) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Changes in Working Capital (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Changes in Working Capital (Quarterly) Range, Past 5 Years

View Changes in Working Capital (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Changes in Working Capital (Quarterly) Benchmarks

View Changes in Working Capital (Quarterly) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Neurocrine Biosciences, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade